New Key Statistics Module, Z-Score and F-Score
XPAR:INFE Key Ratios
Market Cap € M | 71.73 |
Enterprise Value € M | 9.90 |
P/E(ttm) | 36.53 |
PE Ratio without NRI | 72.02 |
Forward PE Ratio | -- |
Price/Book | 1.26 |
Price/Sales | 0.29 |
Price/Free Cash Flow | 19.73 |
Price/Owner Earnings | 6.48 |
Payout Ratio % | 10.12 |
Revenue (TTM) € M | 242.00 |
EPS (TTM) € | 1.67 |
Beneish M-Score | -3.27 |
10-y EBITDA Growth Rate % | 7.50 |
5-y EBITDA Growth Rate % | 28.70 |
y-y EBITDA Growth Rate % | 28.10 |
EV-to-EBIT | 1.82 |
EV-to-EBITDA | 0.40 |
PEG | 2.51 |
Shares Outstanding M | 1.18 |
Net Margin (%) | 0.81 |
Operating Margin % | 0.83 |
Pre-tax Margin (%) | 1.93 |
Quick Ratio | 1.14 |
Current Ratio | 1.15 |
ROA % (ttm) | 0.63 |
ROE % (ttm) | 2.28 |
ROIC % (ttm) | 0.60 |
Dividend Yield % | 14.05 |
Altman Z-Score | 1.16 |
XPAR:INFE Number of Guru Trades
XPAR:INFE Volume of Guru Trades
Gurus Latest Trades with XPAR:INFE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XPAR:INFE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data